======= STARD13 =======
== Gene Information ==
* **Official Symbol**: STARD13
* **Official Name**: StAR related lipid transfer domain containing 13
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=90627|90627]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y3M8|Q9Y3M8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=STARD13&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20STARD13|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609866|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a protein which contains an N-terminal sterile alpha motif (SAM) for protein-protein interactions, followed by an ATP/GTP-binding motif, a GTPase-activating protein (GAP) domain, and a C-terminal STAR-related lipid transfer (START) domain. It may be involved in regulation of cytoskeletal reorganization, cell proliferation, and cell motility, and acts as a tumor suppressor in hepatoma cells. The gene is located in a region of chromosome 13 that is associated with loss of heterozygosity in hepatocellular carcinomas. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011].
* **UniProt Summary**: N/A
|START|
|RhoGAP|
|endothelial tube lumen extension|
|morphogenesis of an endothelium|
|endothelial tube morphogenesis|
|negative regulation of cell migration involved in sprouting angiogenesis|
|negative regulation of sprouting angiogenesis|
|negative regulation of blood vessel endothelial cell migration|
|regulation of cell migration involved in sprouting angiogenesis|
|negative regulation of endothelial cell migration|
|endothelial cell migration|
|negative regulation of epithelial cell migration|
|regulation of sprouting angiogenesis|
|lipid droplet|
|epithelial cell migration|
|epithelium migration|
|regulation of blood vessel endothelial cell migration|
|tissue migration|
|endothelium development|
|mitochondrial membrane|
|negative regulation of angiogenesis|
|negative regulation of blood vessel morphogenesis|
|negative regulation of vasculature development|
|lipid binding|
|regulation of endothelial cell migration|
|ameboidal-type cell migration|
|regulation of epithelial cell migration|
|negative regulation of cell migration|
|negative regulation of cell motility|
|GTPase activator activity|
|regulation of angiogenesis|
|epithelial tube morphogenesis|
|negative regulation of cellular component movement|
|regulation of vasculature development|
|negative regulation of locomotion|
|regulation of small GTPase mediated signal transduction|
|positive regulation of GTPase activity|
|morphogenesis of an epithelium|
|regulation of GTPase activity|
|tissue morphogenesis|
|tube morphogenesis|
|positive regulation of hydrolase activity|
|tube development|
|regulation of cell migration|
|regulation of cell motility|
|negative regulation of developmental process|
|cell migration|
|regulation of locomotion|
|regulation of cellular component movement|
|regulation of anatomical structure morphogenesis|
|cell motility|
|localization of cell|
|epithelium development|
|negative regulation of multicellular organismal process|
|regulation of hydrolase activity|
|locomotion|
|positive regulation of catalytic activity|
|movement of cell or subcellular component|
|tissue development|
|positive regulation of molecular function|
|regulation of intracellular signal transduction|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-1.86|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13371
* **Expression level (log2 read counts)**: 2.92
{{:chemogenomics:nalm6 dist.png?nolink |}}